Drugs / hydroxy-progesterone
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT00123669 | Oct 1997 → May 2020 | breast neoplasm | Tata Memorial Hospital | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hydroxy-progesterone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00123669 ↗ |
| Route | Intramuscular | “An intramuscular injection of 500 mg of depot hydroxy-progesterone 5 to 15 days prior to surgery.” NCT00123669 ↗ |